Telix Pharmaceuticals (Innovations) Pty Limited
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Telix Pharmaceuticals (Innovations) Pty Limited sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Telix Pharmaceuticals (Innovations) Pty Limited: 5 sponsored US clinical trials, 2 recruiting.
Telix Pharmaceuticals (Innovations) Pty Limited sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Retrospective Study, with 1 trials.
Upper-quartile sponsor footprint
Telix Pharmaceuticals (Innovations) Pty Limited sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
NCT07197645
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
NCT06520345
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
NCT07238322
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
NCT06655064
89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study
NCT03849118
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
Where Telix Pharmaceuticals (Innovations) Pty Limited enrollment is open (later-stage tilt)
2 recruiting of 5 indexed (40% open); 1 completed (20%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Retrospective Study (1 trial), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Telix Pharmaceuticals (Innovations) Pty Limited: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Telix Pharmaceuticals (Innovations) Pty Limited sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this Telix Pharmaceuticals (Innovations) Pty Limited page
5 registered trials is a research-attention snapshot, not an endorsement of Telix Pharmaceuticals (Innovations) Pty Limited or any single study.
- 2 of Telix Pharmaceuticals (Innovations) Pty Limited's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Retrospective Study is the condition Telix Pharmaceuticals (Innovations) Pty Limited studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Retrospective Study trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Telix Pharmaceuticals (Innovations) Pty Limited pipeline card: 5 registered trials from official public datasets.Report a data error.